Nomura Holdings Inc Biogen Inc. Transaction History

Nomura Holdings Inc

$50.5 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $650,853 - $783,456	2,924 New	2,924 $756,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $762,167 - $880,708	2,769 New	2,769 $788,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $196,145 - $238,321	777 Added 4.38%	18,505 $5.05 Million
Q3 2022 Nov 15, 2022	BUY	$194.69 - $268.46 $479,132 - $660,680	2,461 Added 16.12%	17,728 $4.69 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $488,354 - $580,744	-2,604 Reduced 14.57%	15,267 $3.28 Million
Q1 2022 May 18, 2022	SELL	$193.77 - $244.14 $2.98 Million - $3.75 Million	-15,356 Reduced 46.22%	17,871 $3.84 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $4.43 Million - $5.7 Million	19,793 Added 147.34%	33,227 $7.99 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $8.95 Million - $11.7 Million	-31,611 Reduced 70.18%	13,434 $3.9 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $11.6 Million - $18.5 Million	44,689 Added 12553.09%	45,045 $16.1 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $8.16 Million - $9.56 Million	-33,590 Reduced 98.95%	356 $100,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $7.6 Million - $11.4 Million	32,148 Added 1787.99%	33,946 $8.31 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $14.2 Million - $16.4 Million	-53,592 Reduced 96.75%	1,798 $507,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $12.7 Million - $16.8 Million	48,933 Added 757.83%	55,390 $15 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $18.6 Million - $23.6 Million	-69,197 Reduced 91.47%	6,457 $2.03 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $30.9 Million - $42.7 Million	-140,333 Reduced 64.97%	75,654 $21.9 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $34.5 Million - $38.7 Million	158,593 Added 276.32%	215,987 $49.5 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $4.12 Million - $4.54 Million	18,778 Added 48.63%	57,394 $13.5 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $2.98 Million - $4.66 Million	13,735 Added 55.2%	38,616 $8.91 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $11.6 Million - $14.6 Million	-41,492 Reduced 62.51%	24,881 $7.6 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $14.5 Million - $19 Million	49,412 Added 291.33%	66,373 $23.3 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $961,322 - $1.15 Million	-3,733 Reduced 18.04%	16,961 $4.05 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $6.72 Million - $9.51 Million	-25,842 Reduced 55.53%	20,694 $5.68 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $5.38 Million - $7.61 Million	20,694 Added 80.08%	46,536 $13.9 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $4.16 Million - $4.66 Million	13,514 Added 109.62%	25,842 $8.24 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $3.47 Million - $4.06 Million	12,328	12,328 $3.87 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account